DiscoverBehind the BreakthroughsMichael Severino: Towards In Vivo Genome Editing of Humans
Michael Severino: Towards In Vivo Genome Editing of Humans

Michael Severino: Towards In Vivo Genome Editing of Humans

Update: 2024-11-21
Share

Description

Michael Severino, MD, discusses the approaches for developing "genome writers" at Tessera Therapeutics, where he joined as CEO in 2022, and the advantages of performing in vivo genome editing over ex vivo approaches. Severino explains where the company is in utilizing its genome writing platform to perform edits in vivo on its journey toward the clinic.


Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.


Produced by Bill Levine

Hosted by Jonathan D. Grinstein, PhD

Music provided by Artem Hramushkin

Audio mixed and mastered by Jason Mack



Hosted on Acast. See acast.com/privacy for more information.

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Michael Severino: Towards In Vivo Genome Editing of Humans

Michael Severino: Towards In Vivo Genome Editing of Humans